Why we give

The diseases we research impact people's lives

Our researchers are dedicated to improving lives through neuroscience. Thanks to the generosity of all our donors, that we can continue our legacy of ground-breaking research.

Brazil Family Foundation 

Bobbie Brazil AO (left) and Lyn Brazil AM (right).

Recognising stroke and motor neurone disease (MND) had only limited treatment options and no cures prompted Lyn and Bobbie Brazil to establish the Brazil Family Program for Neurology in 2017. This enabled us to recruit world-leading researchers and support four laboratories.

Dr Adam Walker’s laboratory has defined some of the early triggers of MND to enable the best targeted approaches for therapies and identified ways to prevent the abnormal accumulation or improve the removal of a protein that causes motor neurons to die.

Dr Tara Walker is examining whether the dietary supplement selenium can prevent or decrease cognitive or motor deficits following stroke.

Dr Matilde Balbi aims to understand how stimulating the cortex in different ways reduces the loss of brain cells after a stroke and whether this mitigates behavioural deficits.

Professor Gail Robinson’s stroke research aims to improve cognitive assessment tests used to evaluate stroke survivors, in the acute phase, to predict long-term outcomes and to develop more targeted, personalised therapy strategies. Professor Robinson also aims to improve our understanding of the biological basis of MND.  

The Brazil Family have also donated generously to our Alzheimer’s disease research. This gift contributed to Professor Jürgen Götz and his team’s ground-breaking therapeutic ultrasound approach to target dementia. This research has identified a range of potential applications for ultrasound, including delivering drugs into the brain. The intention is to modify disease progression and ultimately cure brain diseases.

Discovery research leads to the health outcomes of the future, but it takes time and support. Researchers need preliminary data to support their applications for grants. With government grant funding becoming harder to secure , scientists with promising research potential are being lost.

Funding of researchers who narrowly miss out on government grant funding could hold the key to major breakthroughs and, with support, could continue to explore new avenues and build the data needed to be successful in subsequent grant rounds.

The Brazil Family Foundation understands the power of  “near-miss” applications and are supporting our scientists with a gift which enables them to continue collecting valuable data to improve their grant success in future funding rounds.

The whole of the QBI community pays tribute to the Brazil Family Foundation whose generosity and support enables us to continue our pathway to expanding our understanding of the brain, the underlying causes of  brain disease and  help develop new treatments which will benefit the community at large.
In 2019, the NFIA Patron’s Annual Walk for Charity, along the
Great Ocean Walk, raised over $125 000 to support
brain research.

NFIA Trekkers do the hard yards for QBI

Through the hard work of Brian Davies, a successful businessman and immediate past-president and patron of the National Fire Industry Association (NFIA), and his wife, Liz, QBI was the joint-recipient of a donation of over $250 000 in 2019.
This incredible effort was the result of the NFIA Patron’s Walk held in October, which may sound like a scenic walk in the park but Brian, Liz and seven other NFIA members spent three days enduring driving rain and winds of close to 50 knots coming straight from Antarctica.
The idea for the walk came while the couple were completing the Three Capes Walk to raise money for the Queensland Brain Institute in 2018.
On that walk, Liz suggested to Brian that as the patron of the NFIA, he could create his own walk for charity. Mr Davies believes that corporate Australia has a big responsibility to give back, which is testament to the success of the inaugural walk. The money raised was shared between the Queensland Brain Institute and the Gallipoli Medical Research Foundation (GMRF).
The NFIA walk is the first of three walks to raise money for research at QBI and GMRF, with the aim of raising $500 000 in three years. The donation from the NFIA walk will help QBI’s research into motor neurone disease, dementia, Parkinson’s disease, stroke and QBI’s Discovery Research Endowment fund, which enables fundamental research into major health issues, including depression, anxiety, PTSD and epilepsy. QBI is extremely grateful to Brian and Liz and the NFIA team for their support.

 

The NFIA walk is the first of three walks to raise money for research at QBI and GMRF, with the aim of raising $500 000 in three years.

The Stafford Fox Medical Research Foundation

Paul (Stafford Fox Foundation Trustee) and his wife, Susan, visited QBI in October, 2019, to meet with Professor Pankaj Sah
(QBI Director) and Dr Steven Zuryn and Emeritus Professor Perry Bartlett AO (back row).
In 2019, The Stafford Fox Medical Research Foundation confirmed its continued generous support of the prestigious $2.5 million philanthropically funded international fellowship to Dr Steven Zuryn at the Queensland Brain Institute to fight stroke-induced dementia, also known as vascular dementia. The Foundation also continues to support the work of Emeritus Professor Perry Bartlett’s research into prevention of dementia in ageing by improving cognition through exercise.
The Stafford Fox Medical Research Foundation was established in 2013 following the death of Moyna Fox, and named in honour of her late husband, James Stafford Fox, a former BP Australia chief executive.
Stafford and Moyna Fox started one of Australia’s wealthiest medical research foundations after many years of careful planning, resulting in a fund worth over $100 million. It was only publicly revealed in Moyna’s will when she died in 2013, many years after her husband.
James Stafford Fox was a private person, tall, physically imposing, but without a, particularly dominant personality. He rose from a position as a junior clerk at the Port Melbourne depot of the Commonwealth Oil Refineries (COR) in 1932, to become the first Australian chief executive of BP Australia Ltd in 1971.
James Stafford Fox spent three years at the helm of BP Australia, and retired in 1974 at age 60, remaining on several boards until 1985. By 1990, he was in poor health, suffering, among other things, from dementia. He entered a nursing home and died in 1994. By that time, he had already charted the course that would lead to the establishment of the foundation. Moyna lived on for more than 18 years, knowing what would happen after her death, but never revealing it publicly. Eventually, she too succumbed to dementia and died in 2013. The couple, who were so careful with their money and who clearly had no desire for fame and prominence during their lifetime, will now forever be remembered for their generosity in setting up the Stafford Fox Medical Foundation.
The Foundation’s support of QBI is crucial in enabling Emeritus Professor Bartlett and Dr Steven Zuryn to continue their work in finding solutions for the growing challenge of dementia today. This cutting- edge research is helping put Queensland and Australia at the forefront of world medical research.

What your donations fund

Your support can help us achieve a range of achievements

World leading research

Brightest scientific minds

Solutions to global health challenges

"I think it is important for people with dementia, their families and carers, to know that they are not forgotten, and that there’s a lot of work going on behind the scenes at QBI to try to unravel the tangled web that is dementia."
Robyn Hilton (established the Peter Hilton Senior Research Fellowship in Ageing Dementia)

Hear from one of our supporters


Jeff Maclean, Chair of QBI Advisory Board

Got a story you would like to share?

Are you a donor or supporter of QBI and would like to share your story? We would love to hear from you!

 

Email us
 

Research in action

  • 10 Sep 2025
  • Wray: Statistical and Psychiatric Genetics

    Group Leaders

    Professor Peter Visscher

    Researcher profile is public: 
    1
    Supervisor: 
    Researcher biography: 

    Visscher joined the University of Queensland in 2011, where he is Professor of Quantitative Genetics. He is a Laureate Fellow of the Australian Research Council. Visscher was elected a Fellow of the Australian Academy of Science in 2010, a Fellow of the Royal Society (London) in 2018 and a Foreign Member of the Royal Netherlands Academy of Arts and Sciences in 2018.

    Visscher's research is about genetic variation for complex traits (including quantitative traits and disease) in populations, with the broad aim to understand and quantify the causes and consequences of human trait variation.

    Prof Peter Visscher, Prof Naomi Wray and Prof Jian Yang together comprise the Executive Team of the Program in Complex Trait Genomics (PCTG). PCTG comprises a critical mass of more than 30 post-doctoral researchers plus research assistants and students, all supported by external grant funding. Their skills lie in the ability to develop and apply statistical methods within the framework of quantitative, population and statistical genetics and to use theory to understand and predict results from data analyses. They play leading roles in the international research consortia. The focus of current research activities is in the detection and fine-mapping of loci underlying complex traits (including common disease), based upon theoretical studies and applications of methods to large datasets, in population genetics studies using theoretical approaches and high-density genetic marker data, and in systems genomics studies.

    Body: 

    Professor Peter Visscher: Program in complex trait genomics

    The Visscher laboratory specialises in developing methodology that enables analyses aimed at understanding the genetic basis of differences in risk for disease, and other phenotypes between individuals. This research crosses the boundaries of quantitative and statistical genetics, population genetics and human genetics. Applications are diverse but include the study of cognition, cognitive change, and psychiatric and neurological disorders. 

    Find out more


     


    Research Members

    Dr Qiongyi Zhao

    Research Fellow
    Queensland Brain Institute
    Researcher profile is public: 
    1
    Supervisor: 
    Researcher biography: 

    I am a Research Fellow in Bioinformatics, holding a joint position with QBI the Bredy group (50%) and IMB the Palpant group (50%). With over 15 years of experience in the bioinformatics/NGS field, my journey began with the greenfield development of three NGS platforms: 454, Illumina, and SOLiD. This experience has equipped me with extensive expertise in bioinformatic analysis, particularly in analyzing a variety of NGS data types. As the leader of the bioinformatics core facility at QBI from 2012 to 2022, my role was primarily focused on providing bioinformatics services. However, I have also been actively engaged in custom programming and analysis for numerous projects, allowing me to make significant intellectual contributions and deepen my involvement in research studies. Despite the typical service-oriented position of bioinformaticians, my publication record is notable, featuring over 40 peer-reviewed publications, with me serving as the first, co-first, or last author on 16 of them. Since 2019, my work has garnered 1,525 citations (as per Google Scholar, as of 12 Jan 2024), with 41.2% of my publications ranking in the top 10% of journals based on the CiteScore Percentile Source from SciVal. My contributions to bioinformatics are showcased in prestigious journals, with notable examples including lncRNA capture sequencing and ATAC-seq data analysis (Nature Communications, 2023) and (Cell Reports, 2022), de novo transcriptome assembly (Development, 2022), noncanonical structure Z-DNA analysis (Nature Neuroscience, 2020), DNA modification m6dA data analysis (Nature Neuroscience, 2019), whole-exome sequencing data analysis (Genome Medicine, 2017), and cross-ethnic meta-analysis (Nature Communications, 2017).


    Students

Pages

Connect with us

           ​